ConforMIS, Inc., a Burlington, Mass.-based medical-device company, has raised $89m in a Series E funding round.
Additional funds beyond this amount will be provided upon meeting certain milestones.
Backers include AGC Equity Partners and Axel Johnson, Inc., along with Government Investment Funds from Asia and the UAE.
The company intends to use the funds to support ongoing sales and marketing expansion, R&D investment into new product lines, and build out of manufacturing infrastructure.
Founded in 2004, and led by Philipp Lang, MD, MBA, CEO and Chairman of the Board, ConforMIS has built and brought to market a full line of patient-specific implants and instruments for the treatment of knee osteoarthritis. In 2010, the company launched their second generation personalized partial knee solutions, the iUni® G2 andiDuo® G2. In 2011, ConforMIS received 510(k) clearance from the United States Food and Drug Administration to market the iTotal® CR Knee Replacement System, a specific total knee implant on the market.